- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
- 10-Q Quarterly report
- 10.1 Letter Amendment to the Enzyme and Product Supply Agreement
- 10.2 Letter Amendment to the Product Supply Agreement
- 10.3 Amd NO.1 to the Memo of Understanding for Transfer Pricing & Royalty Calculation
- 10.4 Amendment NO.1 to the Memorandum of Understanding for Transfer Pricing
- 10.5 Omnibus Letter Amendment to the Enzyme and Product Supply Agreement
- 10.6 Letters of Amendment and Acknowledgment
- 31.1 Certification of Peo Required Under Rule 13A-14(A) and 15D-14(A)
- 31.2 Certification of Pfo Required Under Rule 13A-14(A) and 15D-14(A)
- 32.1 Certification of Peo and Pfo Required Under Rule 13A-14(B)
Exhibit 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Codexis, Inc. (the “Company”) on Form 10-Q for the fiscal quarter ended September 30, 2011, as filed with the Securities and Exchange Commission (the “Report”), Alan Shaw, President and Chief Executive Officer of the Company and Robert Lawson, Senior Vice President and Chief Financial Officer of the Company, respectively, do each hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
• | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
• | The information in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
Date: November 7, 2011 | ||
/s/ Alan Shaw | ||
Alan Shaw President and Chief Executive Officer |
/s/ Robert Lawson | ||
Robert Lawson Senior Vice President and Chief Financial Officer |